This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Treatment With Itraconazole

Sandra M. DePadova-Elder, MD; Chérie M. Ditre, MD; Gary R. Kantor, MD; Peter J. Koblenzer, MD

Arch Dermatol. 1994;130(1):19-22.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The Cutting Edge: Challenges in Medical and Surgical Therapeutics

REPORT OF A CASE

An 18-year-old Hispanic woman presented with a slowly progressive and cosmetically disfiguring dystrophy of her fingernails that began at 4 years of age and that recently began to involve her toenails. Her medical history was significant for several episodes of oral candidiasis, hypoparathyroidism, adrenocortical failure (Addison's disease), and ovarian failure. She was receiving replacement therapy with hydrocortisone, fludrocortisone acetate, estrogen, calcium, and vitamin D for her endocrinopathies. There was no family history of skin, hair, or nail disease or endocrinopathy.

The findings from her physical examination revealed severely dystrophic fingernails with some proximal nail fold hyperpigmentation (Figure 1). Also noted was dystrophy of the left great toenail and early involvement of the left second toenail. Patchy hyperpigmentation of the buccal mucosa and hard palate with superficial whitish plaques were observed (Figure 2). The dentition appeared normal. Cultures . . . [Full Text PDF of this Article]

Author Affiliations
Hahnemann University, Philadelphia, Pa

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?